Literature DB >> 10576519

Visceral obesity and diabetes.

P Björntorp1, R Rosmond.   

Abstract

Visceral obesity is a strong predictor of type 2 (non-insulin-dependent) diabetes and is associated with insulin resistance. In addition, research has indicated that the accumulation of visceral fat is regulated by endocrine mechanisms. Data suggest that progressive malfunction of the hypothalamic-pituitary-adrenal (HPA) axis, with elevation of levels of cortisol and reductions in levels of sex steroids and growth hormone, is associated with visceral accumulation of fat that contributes to circulating levels of free fatty acids, and that these factors are implicated in the development of insulin resistance. Furthermore, failure of central feedback control of the HPA axis by glucocorticoid receptors (GR) appears to be correlated with polymorphisms near the first exons of the GR gene. The HPA axis disturbances are similar to those seen after prolonged exposure to environmental stress. Psychosocial and socioeconomic factors, alcohol, depressive traits and anxiety are linked to HPA axis abnormalities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10576519     DOI: 10.2165/00003495-199958001-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  26 in total

1.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

2.  Cortisol secretion in relation to body fat distribution in obese premenopausal women.

Authors:  P Mårin; N Darin; T Amemiya; B Andersson; S Jern; P Björntorp
Journal:  Metabolism       Date:  1992-08       Impact factor: 8.694

3.  Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock.

Authors:  P Linkowski; A Van Onderbergen; M Kerkhofs; D Bosson; J Mendlewicz; E Van Cauter
Journal:  Am J Physiol       Date:  1993-02

Review 4.  Current status of the human obesity gene map.

Authors:  C Bouchard; L Pérusse
Journal:  Obes Res       Date:  1996-01

5.  Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus.

Authors:  P Björntorp; G Holm; R Rosmond
Journal:  Diabet Med       Date:  1999-05       Impact factor: 4.359

6.  Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance.

Authors:  K E Zakrzewska; I Cusin; A Sainsbury; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

7.  The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913.

Authors:  L O Ohlson; B Larsson; K Svärdsudd; L Welin; H Eriksson; L Wilhelmsen; P Björntorp; G Tibblin
Journal:  Diabetes       Date:  1985-10       Impact factor: 9.461

8.  Human glucocorticoid receptor gene deletion following exposure to cancer chemotherapeutic drugs and chemical mutagens.

Authors:  L A Palmer; B Hukku; J M Harmon
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

9.  The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.

Authors:  R Pasquali; S Cantobelli; F Casimirri; M Capelli; L Bortoluzzi; R Flamia; A M Labate; L Barbara
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

Review 10.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.

Authors:  G P Chrousos; P W Gold
Journal:  JAMA       Date:  1992-03-04       Impact factor: 56.272

View more
  15 in total

Review 1.  The metabolic syndrome.

Authors:  O Bosello; M Zamboni
Journal:  Eat Weight Disord       Date:  2002-06       Impact factor: 4.652

Review 2.  Fat circadian biology.

Authors:  Jeffrey M Gimble; Z Elizabeth Floyd
Journal:  J Appl Physiol (1985)       Date:  2009-05-21

3.  Selective parasympathetic innervation of subcutaneous and intra-abdominal fat--functional implications.

Authors:  Felix Kreier; Eric Fliers; Peter J Voshol; Corbert G Van Eden; Louis M Havekes; Andries Kalsbeek; Caroline L Van Heijningen; Arja A Sluiter; Thomas C Mettenleiter; Johannes A Romijn; Hans P Sauerwein; Ruud M Buijs
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls.

Authors:  J Ruppert; D Hartung; M Westhoff-Bleck; J Herrmann; B Stubbs; J Cordes; T H C Krüger; R Lichtinghagen; K G Kahl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-23       Impact factor: 5.270

Review 5.  Increased mortality in depressive disorders: a review.

Authors:  Pim Cuijpers; Robert A Schoevers
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 5.285

6.  Diagnosed diabetes and ethnic disparities in adverse health behaviors of American women.

Authors:  Ike S Okosun; Mark Glodener; G E Alan Dever
Journal:  J Natl Med Assoc       Date:  2003-07       Impact factor: 1.798

7.  Changes in anabolic and catabolic activity among women taking part in an alternative labour market programme.

Authors:  Hugo Westerlund; Anna Bergström; Töres Theorell
Journal:  Integr Physiol Behav Sci       Date:  2004 Jan-Mar

8.  Associations between insulin and heart rate variability in police officers.

Authors:  Luenda E Charles; Michael E Andrew; Khachatur Sarkisian; Li Shengqiao; Anna Mnatsakanova; John M Violanti; Mark Wilson; Ja K Gu; Diane B Miller; Cecil M Burchfiel
Journal:  Am J Hum Biol       Date:  2013-10-18       Impact factor: 1.937

9.  Attenuating effect of vigorous physical activity on the risk for inherited obesity: a study of 47,691 runners.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

10.  Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe?

Authors:  Alistair Vw Nunn; Jimmy D Bell; Geoffrey W Guy
Journal:  Nutr Metab (Lond)       Date:  2009-04-16       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.